glp 1 supergut reviews Supergut, the Leader in GLP-1 Functional Foods, Accelerates Its Unprecedented Retail Expansion With Newest Partner, GNC Supergut Gut Healthy Flavored GLP-1

Superguts $22 million Series B was led by Full Frame Growth Partners, and brought the startups total funding to approximately $36 million

Treat initial VWAP tests as decision points

Retatrutide is an investigational medication not yet approved by the FDA

For individuals with obesity, type 2 diabetes, or cardiovascular risk factors, the documented benefits of GLP-1 medications on weight, blood sugar, cardiovascular outcomes, and in some cases kidney and liver health are substantial

They work by enhancing insulin secretion, delaying gastric emptying, and reducing appetite

Detailed information on these datasets was provided in Supplementary Table S1